Extended latanoprost release from commercial contact lenses: in vitro studies using corneal models.
In this study, we compared, for the first time, the release of a 432 kDa prostaglandin F2a analogue drug, Latanoprost, from commercially available contact lenses using in vitro models with corneal epithelial cells. Conventional polyHEMA-based and silicone hydrogel soft contact lenses were soaked in...
Main Authors: | Saman Mohammadi, Lyndon Jones, Maud Gorbet |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0106653 |
Similar Items
-
Corneal alterations induced by topical application of commercial latanoprost, travoprost and bimatoprost in rabbit.
by: Wensheng Chen, et al.
Published: (2014-01-01) -
Correction: Corneal Alterations Induced by Topical Application of Commercial Latanoprost, Travoprost and Bimatoprost in Rabbit
by: The Staff
Published: (2014-01-01) -
Correction: Corneal Alterations Induced by Topical Application of Commercial Latanoprost, Travoprost and Bimatoprost in Rabbit.
Published: (2014-01-01) -
In vitro and in vivo performance of epinastine hydrochloride-releasing contact lenses.
by: Takahiro Minami, et al.
Published: (2019-01-01) -
In vitro release of two anti-muscarinic drugs from soft contact lenses
by: Hui A, et al.
Published: (2017-09-01)